Vorinostat in Combination with Pegylated Liposomal Doxorubicin (PLD) and Bortezomib (B) in Patients with Relapsed/Refractory Multiple Myeloma (R/R MM): Final Results of a Phase I Study,

Autor:	Voorhees, Peter M., Gasparetto, Cristina, Osman, Keren *, Richards, Kristy L., Ferraro, Madlyn *, Garcia, Reynaldo *, MacLean, Jennifer *, Winans, Diane *, Moore, Dominic *, Strader, John *, Orlowski, Robert Z., Hurd, David Duane
Zdroj:	In Blood 18 November 2011 118(21):3985-3985
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu